Accuray (ARAY) Acquisitions (2011 - 2023)

Accuray's (ARAY) quarterly Acquisitions came in at $59000.0 in Q1 2023, down 98.47% quarter-over-quarter from $3.9 million in Q3 2012.

Accuray (ARAY) Acquisitions (2011 - 2023) Analysis & Trends

Accuray's Acquisitions history runs 3 years deep, the most recent figure standing at $59000.0 for Q1 2023.

On a quarterly basis, Acquisitions changed N/A year-over-year to $59000.0 in Q1 2023; TTM through Mar 2024 was $59000.0, a 0.0% change from a year earlier, with the FY2013 full-year figure at $3.9 million, up 178.97% from the prior year.
Acquisitions retreated to $59000.0 in Q1 2023 per ARAY's latest filing, from $3.9 million in the prior quarter.
Across five years, Acquisitions topped out at $59000.0 in Q1 2023 and bottomed at $59000.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	22.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	523.00 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-268.10 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	2.30 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Accuray	29,832.96	-38.50 Mn	25.29 Mn	-

Download Data